Education
About Us
Working with TipRanks
Follow Us
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
Total Valuation
Xtl Bio has a market cap or net worth of 38.78M. The enterprise value is ―.
Market Cap38.78M
Enterprise Value―
Share Statistics
Xtl Bio has 881,385,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding881,385,250
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Xtl Bio’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -34.46%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-34.46%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-178.20K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Xtl Bio is -2.86K. Xtl Bio’s PEG ratio is 0.07.
PE Ratio-2.86K
PS Ratio0.00
PB Ratio1.14
Price to Fair Value2.30
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.07
Income Statement
In the last 12 months, Xtl Bio had revenue of 0.00 and earned -1.78K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-765.00K
Pretax Income-1.78M
Net Income-1.78K
EBITDA-764.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Xtl Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change-58.59%
50-Day Moving Average4.63
200-Day Moving Average6.90
Relative Strength Index (RSI)48.13
Average Volume (3m)541.20K
Important Dates
Xtl Bio upcoming earnings date is Dec 5, 2023, TBA Not Confirmed.
Last Earnings DateMay 31, 2023
Next Earnings DateDec 5, 2023
Ex-Dividend Date―
Financial Position
Xtl Bio as a current ratio of 9.93, with Debt / Equity ratio of 2.94%
Current Ratio9.93
Quick Ratio10.07
Debt to Market Cap0.00
Net Debt to EBITDA1.83
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Xtl Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Xtl Bio EV to EBITDA ratio is -4.84, with an EV/FCF ratio of -5.23.
EV to Sales0.00
EV to EBITDA-4.84
EV to Free Cash Flow-5.23
EV to Operating Cash Flow-5.23
Balance Sheet
Xtl Bio has 2.34M in cash and marketable securities with $0.00 in debt, giving a net cash position of -2.34M billion.
Cash & Marketable Securities2.34M
Total Debt$0.00
Net Cash-2.34M
Net Cash Per Share>-0.01
Tangible Book Value Per Share<0.01
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Xtl Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―